Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
Radiotherapie en chirurgie met of zonder pembrolizumab bij stadium III-wekedelensarcoom
feb 2025 | Bot en wekedelentumoren, Immuuntherapie